TotalMarketCap

Xeris Biopharma

XERSNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.370 B

$13.00 +24.29%

Close of 6 Nov 2026

As of 6 Nov 2026, Xeris Biopharma (XERS) has a market capitalization of $2.37B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$291.8M

#2126 by revenue

Earnings

$554.0K

#2390 by earnings

Shares outstanding

182,700,038

Latest filing cover page

P/E ratio

4278.3

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #81HUTCHMED (China)HCM$2.48B
  2. #82Palvella TherapeuticsPVLA$2.48B
  3. #83Xeris BiopharmaXERS$2.37B
  4. #84MBX BiosciencesMBX$2.34B
  5. #85PharvarisPHVS$2.28B

What if Xeris Biopharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$154,875.09

Per share 11,913× higher

Bitcoin $1.53T

$8,380.02

Per share 645× higher

Apple $5.02T

$27,510.83

Per share 2,116× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Xeris Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.